|
May 22
|
Akari Therapeutics to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
|
|
May 1
|
Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology
|
|
Jan 2
|
Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing
|
|
Dec 14
|
Akari Therapeutics to Present at Biotech Showcase 2024
|
|
Dec 1
|
Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors
|
|
Nov 16
|
Akari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference
|
|
Nov 6
|
Akari Therapeutics to Present a Poster on Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference
|
|
Sep 5
|
Akari Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
|